TEPP-46 and DASA-58 are two different small-molecule agonists of PKM2 and both can promote the formation of the PKM2 tetramer, which can not only inhibit the growth of tumor cells but also inhibit the inflammatory response of immune cells by promoting the formation of the PKM2 tetramer (29–31). Here, PKM is linked to neoplasm.